Characterization and temporal regulation of mRNAs encoded by vaccinia virus intermediate-stage genes.
about
Vaccinia virus A30L protein is required for association of viral membranes with dense viroplasm to form immature virions.Viral double-stranded RNAs from vaccinia virus early or intermediate gene transcripts possess PKR activating function, resulting in NF-kappaB activation, when the K1 protein is absent or mutatedReverse genetics analysis of poxvirus intermediate transcription factorsVaccinia virus activation of CCR5 invokes tyrosine phosphorylation signaling events that support virus replicationIdentification of novel antipoxviral agents: mitoxantrone inhibits vaccinia virus replication by blocking virion assembly.Comparative analysis of viral gene expression programs during poxvirus infection: a transcriptional map of the vaccinia and monkeypox genomes.A glutaredoxin, encoded by the G4L gene of vaccinia virus, is essential for virion morphogenesis.Down regulation of gene expression by the vaccinia virus D10 protein.The vaccinia virus A18R DNA helicase is a postreplicative negative transcription elongation factor.Regulation of viral intermediate gene expression by the vaccinia virus B1 protein kinase.Characterization of a vaccinia virus mutant with a deletion of the D10R gene encoding a putative negative regulator of gene expression.Molecular chaperone Hsp90 is important for vaccinia virus growth in cellsRestriction of vaccinia virus replication by a ced-3 and ced-4-dependent pathway in Caenorhabditis elegansCharacterization of a second vaccinia virus mRNA-decapping enzyme conserved in poxviruses.Smallpox vaccines: targets of protective immunity.Regulation of gene expression by reiterative transcriptionIdentification of a transcription factor, encoded by two vaccinia virus early genes, that regulates the intermediate stage of viral gene expression.Genome-wide analysis of the 5' and 3' ends of vaccinia virus early mRNAs delineates regulatory sequences of annotated and anomalous transcripts.Poxvirus decapping enzymes enhance virulence by preventing the accumulation of dsRNA and the induction of innate antiviral responsesA cellular factor is required for transcription of vaccinia viral intermediate-stage genes.Expression profiling of the intermediate and late stages of poxvirus replication.Deciphering poxvirus gene expression by RNA sequencing and ribosome profiling.Vaccinia virus D10 protein has mRNA decapping activity, providing a mechanism for control of host and viral gene expression.Vaccinia virus gene A18R encodes an essential DNA helicasePhenotypic characterization of mutants in vaccinia virus gene G2R, a putative transcription elongation factor.Poxvirus DNA topoisomerase knockout mutant exhibits decreased infectivity associated with reduced early transcription.Pervasive initiation and 3'-end formation of poxvirus postreplicative RNAs.Stable expression of the vaccinia virus K1L gene in rabbit cells complements the host range defect of a vaccinia virus mutant.Modification of the cascade model for regulation of vaccinia virus gene expression: purification of a prereplicative, late-stage-specific transcription factor.Overexpression, purification, and late transcription factor activity of the 17-kilodalton protein encoded by the vaccinia virus A1L geneMutational analysis of a predicted zinc-binding motif in the 26-kilodalton protein encoded by the vaccinia virus A2L gene: correlation of zinc binding with late transcriptional transactivation activity.Kinetic analysis of a complete poxvirus transcriptome reveals an immediate-early class of genesInhibition of the ubiquitin-proteasome system prevents vaccinia virus DNA replication and expression of intermediate and late genesA novel recombinant vaccinia virus expressing the human norepinephrine transporter retains oncolytic potential and facilitates deep-tissue imaging.Cascade regulation of vaccinia virus gene expression is modulated by multistage promoters.Interaction of the vaccinia virus RNA polymerase-associated 94-kilodalton protein with the early transcription factor.The D10 decapping enzyme of vaccinia virus contributes to decay of cellular and viral mRNAs and to virulence in miceRole of viral factor E3L in modified vaccinia virus ankara infection of human HeLa Cells: regulation of the virus life cycle and identification of differentially expressed host genes.Development of Vaccinia reporter viruses for rapid, high content analysis of viral function at all stages of gene expression.Phenotypic analysis of a temperature sensitive mutant in the large subunit of the vaccinia virus mRNA capping enzyme.
P2860
Q24529142-9AD0C24D-8047-44D0-9786-D2532953DD5FQ24609947-2EF6C027-EC89-4935-8BDA-4F916B06C235Q24620092-6DB6EC7F-D178-4180-99B2-593775E43C14Q30540518-84DBCE00-CA73-4B6E-AFBF-0086468CEA23Q33302240-53895F6E-BEB9-47DF-B83A-FDB6B362E819Q33350226-C2BB19F8-8A43-475B-85A0-3685B3657C3BQ33604728-255A0158-0957-435D-AF1E-72F856717911Q33639877-7CD8F2E1-AD7A-434B-95DF-B013B8898ACEQ33783723-88EF805E-DA8C-4810-BDB9-3BE2C803CE68Q33839103-BD81FF0E-615B-4798-891E-AB9744BD5349Q34301810-837F202A-88E6-41D4-BE24-35B49145763DQ34330496-87511288-44E6-4EF4-B40C-6300CF6BD3D9Q34424934-54266341-3AD8-4B8D-AE08-F7F8612C14DBQ34690881-FDF921C4-65B4-45FD-B1F1-97F053CBA0AAQ34780607-6A97BB5A-7484-4349-A17A-EB6FE8EF8ECAQ34809962-BF04663D-6634-466E-8E96-B6201144F38DQ35058993-E3150A46-9377-41F2-A863-86A83E5F8D34Q35076980-E9A786EB-85A0-4D45-B371-BBA168672C5BQ35177770-0A6229B3-6028-420E-8510-B05BEAD63C98Q35198054-34708295-157D-44F0-A641-879DD088D4FBQ35383164-40811D0F-A6D3-4B94-AFF8-5C66C649BE19Q35611968-2A8D59FA-DD6C-4017-84DD-F6D409C1A3B4Q35628538-75542113-AFD9-43F9-A745-214D6303EFABQ35847773-478ABD6E-6994-4D07-AD2E-9A7605662B5FQ35853179-CCA3BF4F-2A2E-484C-B918-2A3CA8698AD4Q36160688-DE125D58-1998-4B40-8713-88BBA2204682Q36225693-E6022516-B812-47A7-B47C-DFBE394F3894Q36621273-13951C6B-2BC6-4309-82E9-40F0E22B1FEAQ36633867-9A3D1972-2C03-414F-8E63-248E9A76F0DCQ36652885-0B2275DE-1596-468B-B900-FA17629DA1AFQ36652907-BCCFC58E-D61A-4610-9395-BB417774065FQ36890933-4476EB19-E3CA-47F8-9E65-E212AFCD7CAEQ37110640-70140151-066A-4665-B888-60A9C2D122AFQ37126192-BC5BB98E-0730-4FA1-ADCA-4EF8A836854DQ37341397-9C9FDF23-511F-48CD-A961-CD44F549C629Q37452102-737CBE8A-938E-432F-8FFB-44D112CEE32BQ37547637-8DA69371-648A-432B-975C-00E38DAF6469Q38331191-D12398B2-C4EE-4A0B-A914-9E14C8466C5DQ38534549-F083CAB5-D505-4143-86B9-C2F247C31FA0Q38632221-A5364CDE-9DC0-4138-80BE-B0957BC11649
P2860
Characterization and temporal regulation of mRNAs encoded by vaccinia virus intermediate-stage genes.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Characterization and temporal ...... irus intermediate-stage genes.
@ast
Characterization and temporal ...... irus intermediate-stage genes.
@en
type
label
Characterization and temporal ...... irus intermediate-stage genes.
@ast
Characterization and temporal ...... irus intermediate-stage genes.
@en
prefLabel
Characterization and temporal ...... irus intermediate-stage genes.
@ast
Characterization and temporal ...... irus intermediate-stage genes.
@en
P2860
P1433
P1476
Characterization and temporal ...... irus intermediate-stage genes.
@en
P2093
P2860
P304
P407
P577
1993-06-01T00:00:00Z